Dr. Hillel Galitzer
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Dr. Hillel Galitzer
Dr. Hillel Galitzer was last confirmed as COO at Entera Bio Ltd. (ENTX) in a filing dated August 15, 2023. The proxy statement of Entera Bio Ltd. reports total compensation of $621 for Dr. Hillel Galitzer in fiscal 2022, including a base salary of $287. Disclosed compensation is on record for 3 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2023-08-15
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2022 | Entera Bio Ltd. (ENTX) | Chief Operating Officer | $287 | $621 |
| 2021 | Entera Bio Ltd. (ENTX) | Chief Operating Officer | $319 | $640 |
| 2020 | Entera Bio Ltd. (ENTX) | Chief Operating Officer | $292 | $527 |
Recent activity
No call appearances or filed executive changes recorded yet.